Darapladib CAS356057-34-6
Darapladib, is a novel inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme that may link lipid metabolism with inflammation, leading to the increased stability of atherosclerotic plaques present in the major arteries. Darapladib is being studied as a possible add-on treatment for atherosclerosis
contact now
Leave a message
If you have any question about the COA or Samples,pls write down your needs,our sales will try to answer you in 24 hours. Thank you for your attention!